556sek
-1,2 %
Date:2026-09-14Time:10:26:48Latest report:Q2-2026List:First NorthTicker:NANEXA
Market Cap:1 068 msekEnterprise Value:1 016 msekNet Sales:33,9 msekEarnings:-24,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:5,56
MA50:4,53
MA200:3,85
Price/MA200:45,1 %
RSI (14):62,3
Price/MA50:23,4 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment